Further experiments with additional melanoma cell lines (Me41, Me64) suggested no evident correlation between TRAIL-R2 expression levels and extent of T cell activation (Supplementary Figure 3), while no activation was seen in the presence of TRAIL R2 negative BT-474 cell line (Figures 4B,C). The gene discussed is TNFRSF10B; the disease is melanoma.